-/-null mice were generated and backcrossed for ≥12 times onto the C57BL/6 background. 23 All procedures were approved by the University of Virginia Animal Care and Use Committee. Male mice at 6 months of age were studied. Body weight, blood glucose, plasma insulin and biochemistry, insulin tolerance, and systolic BP were monitored. Twenty-four-hour urine samples were collected to evaluate the urinary levels of albumin-to-creatinine ratio. Renal interstitial fluid was collected to determine angiotensin II level. Kidneys were harvested for protein and total RNA extraction, and parts were also fixed with Bounin fixative for immunohistochemical analysis of PRR, Abstract-The carcinoembryonic antigen-related cell adhesion molecule 1 regulates insulin sensitivity by promoting hepatic insulin clearance. Mice bearing a null mutation of Ceacam1 gene (Cc1 -/-) develop impaired insulin clearance followed by hyperinsulinemia and insulin resistance, in addition to visceral obesity and increased plasma fatty acids. Because insulin resistance is associated with increased blood pressure, we investigated whether they develop higher blood pressure with activated renal renin-angiotensin system and whether this is mediated, in part, by the upregulation of renal (pro)renin receptor (PRR) expression. Compared with age-matched wild-type littermates, Cc1 -/-mice exhibited increased blood pressure with increased activation of renal renin-angiotensin systems and renal PRR expression. Cytoplasmic and nuclear immunostaining of phospho-PI3K p85α and phospho-Akt was enhanced in the kidney of Cc1 -/-mice. In murine renal inner medullary collecting duct epithelial cells with lentiviral-mediated small hairpin RNA knockdown of carcinoembryonic antigen-related cell adhesion molecule 1, PRR expression was upregulated and phosphorylation of PI3K (Tyr508), Akt (Ser473), NF-κB p65 (Ser276), cAMP response element-binding protein/activated transcription factor (ATF)-1 (Ser133), and ATF-2 (Thr71) was enhanced. Inhibiting PI3K with LY294002 or Akt with Akt inhibitor VIII attenuated PRR expression. In conclusion, global null deletion of Ceacam1 caused an increase in blood pressure with increased renin-angiotensin system activation together with upregulation of PRR via PI3K-Akt activation of cAMP response element-binding protein Table) . Moreover,
I
nsulin resistance is commonly associated with visceral obesity, hypertension, and hyperinsulinemia. [1] [2] [3] [4] [5] It is also associated with increased activity of the rennin-angiotensin system (RAS). 6, 7 Experimental studies and clinical trials demonstrated that blocking RAS components attenuates or improves certain aspects of the clinical manifestation of this syndrome. [8] [9] [10] [11] Several nutritionally and chemically induced in addition to genetically engineered mouse models of insulin resistance and obesity have been generated, 12, 13 but few have been fully characterized for increased blood pressure (BP). Mice bearing a null mutation of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1, Cc1 -/-) exhibit hyperinsulinemia resulting from impaired insulin clearance. 14, 15 Hyperinsulinemia in these mice causes insulin resistance in addition to increased hepatic lipid production and redistribution of the white adipose depot to cause visceral adiposity and a rise in plasma free fatty acids.
14 Because insulin resistance is commonly associated with hypertension, 4, 5 this study was conducted to evaluate whether Cc1 -/-mice develop an elevation in BP with activation of RAS and higher expression of (pro)renin receptor (PRR), a new component of RAS, 16, 17 which is associated with increased BP and diabetic nephropathy.
phospho-PI3K p85α (Tyr 508), and phospho-Akt (Ser473). Renal PRR expression was also evaluated with semiquantitative real-time polymerase chain reaction and Western blotting. Procedures are detailed in the online-only Data Supplement.
Mouse renal inner medullary collecting duct (IMCD) epithelial cells were subjected to small hairpin RNA (shRNA) transduction with mouse CEACAM1 and scramble lentiviral particles (Santa Cruz Biotechnology, Santa Cruz, CA) per manufacturer's instruction. Stable shRNA expression was assessed using quantitative real-time polymerase chain reaction, Western blot analysis, and immunofluorescence staining ( Figure S1 in the online-only Data Supplement). In some experiments, shRNA-transducted IMCD cells were treated with PI3K kinase inhibitor LY294002, Akt kinase inhibitor II (EMD Millipore, Billerica, MA), and CREB-binding protein (CBP)-cAMP response element (CRE)-binding protein (CREB) interaction inhibitor (CalBiochem, La Jolla, CA), as detailed in the online-only Data Supplement.
Binding of CREB-1 and activator protein 1 (AP-1) to their corresponding regulatory elements (CRE and AP-1, respectively) on murine PRR promoter was examined by chromatin immunoprecipitation assay (online-only Data Supplement).
Data analysis was carried out using STATISTICA version 5.0 (StatSoft, Tulsa OK). Results are expressed as mean±SEM. Comparisons among different treatment groups were evaluated by ANOVA with repeated measures, and the Bonferroni correction method as a post hoc test. P<0.05 was statistically significant.
Results

Metabolic Phenotyping of Cc1 -/-Mice
As previously shown, 14 6-month-old Cc1 -/-mice exhibited higher body weight, visceral obesity, plasma free fatty acids, fed blood glucose levels, and hyperinsulinemia compared with age-matched wild-type littermates (Cc1 +/+ ; Table) . Moreover,
Cc1
-/-exhibited reduced insulin tolerance relative to wild-type animals ( Figure 1A ), consistent with hyperinsulinemia-euglycemic clamp analysis showing the development of systemic insulin resistance in these mice. 14, 15 Although the mice are insulin resistant, they did not develop overt diabetes mellitus, as manifested by normal fasting glucose level (Table) , consistent with no effect of Ceacam1 deletion on β-cell function.
14
Elevation in BP and Upregulation of RAS Components in Murine Kidneys
Because insulin resistance is associated with changes in BP, we then evaluated this parameter. Cc1 -/-mice exhibited Figure 1B ) and urine albumin-to-creatinine ratio ( Figure 1C ). Moreover, their mRNA and protein levels of renal renin, angiotensin-converting enzyme, angiotensinogen, and angiotensin II type I receptor were also elevated ( Figure 1E-1L) . Cc1 -/-mice had significantly higher levels of renal interstitial fluid angiotensin II than Cc1 +/+ mice ( Figure 1D ).
Elevated Renal PRR Expression in Cc1 -/-Kidneys
Because PRR is associated with a rise in BP, we examined its expression level in the kidney of these mice. Renal PRR mRNA ( Figure 2A ) and protein levels ( Figure 2B ) were elevated in Cc1 -/-mice. Immunohistochemical staining revealed enhanced PRR expression in glomeruli and proximal tubules (PTs), distal tubules, and collecting ducts ( Figure 2C ). Of note, immunoglobulin G control was done for all immunohistochemical staining protocols and is shown in Figure S2 .
Increased Activation of PI3K/Akt Pathways in Cc1
-/-
Kidneys
Immunohistochemical staining showed increased phosphorylation of PI3K p85α (Tyr 508) in the renal glomeruli, PTs, distal tubules, and collecting ducts in Cc1 -/-mice ( Figure 3A ). Consistently, phosphorylation of Akt (Ser473) was also elevated in the cytosol and nuclei of renal glomeruli, PTs, distal tubules, and particularly, in collecting ducts of Cc1 -/-mice ( Figure 3B ).
Increased PRR Expression and Activation of the PI3K-Akt Pathway in CEACAM1 Knockdown IMCD Cells
Next, we examined whether Ceacam1 deletion exerts a cell autonomous effect on PRR expression. Lentiviral-mediated shRNA knockdown of CEACAM1 in IMCD ( Figure S1 ) caused a significant rise in PRR mRNA and protein expression ( Figure 4A and 4B, KN versus scrambled [Sc] cells in the absence of inhibitors; Figure S3 ). This was accompanied by increased PI3K enzymatic activity ( Figure 4E ), as supported by elevated translocation of total and phosphorylated PI3K p85α (Tyr 508) from cytosol to the cell membrane and nucleus ( Figure 4C ). Consistently, CEACAM1 reduction caused accumulation of activated Ser473-and Thr308-phosphorylated Akt in the nucleus ( Figure 4D ). The increase in PRR expression in shRNA CEACAM1-transducted IMCD cells was significantly prevented by inhibitors of PI3K (LY294002) and Akt (inhibitor II; Figure 4A and 4B, respectively).
Inhibiting Akt-Downstream CBP-CREB Interaction Prevented Elevation of PRR Expression in CEACAM1 Knockdown IMCD Cells
Akt blockade at 5, 15, 30, and 60 minutes significantly increased phosphorylation of CREB/activated transcription factor (ATF)-1 (Ser133), ATF-2 (Thr71), and NF-κB p65 (Ser276) in a timedependent manner in IMCD cells with intact (scrambled [Sc]), but not reduced CEACAM1 expression (KN; Figure 5A ). Moreover, the rise of PRR expression in CEACAM1 knockdown IMCD cells was significantly inhibited by 12-hour treatment with naphthamide compound, a CBP-CREB interaction inhibitor, in a dose-dependent manner at both mRNA and protein levels ( Figure 5B ). This suggests a role for CREB family in Akt-mediated CEACAM1 regulation of PRR in IMCD cells.
CREB Family Members Bind to CRE and AP-1 Regulatory Elements to Enhance PRR Expression
Computational analysis mapped 1 CRE and 5 AP-1 regulatory elements in murine PRR promoter ( Figure 6A ). Chromatin immunoprecipitation analysis showed no significant difference in c-Jun-binding activity to any AP-1 site in PRR promoter between scramble and CEACAM1-shRNA-transducted IMCD cells (data not shown). In contrast, the binding activity of CREB-1 to CRE was about 6-fold higher in CEACAM1 knockdown cells ( Figure 6B) . Similarly, the binding activity of ATF-1 and ATF-2 to CRE was also elevated in these cells, albeit to a lower extent than CREB-1 ( Figure 6C and 6D) . In the absence of CEACAM1, CREB-1 and ATF-1 bound more significantly to AP-1.4 site, with a stronger effect by ATF-1 ( Figure 6E-6G) , and CREB-1 and ATF-2 bound more significantly (by ≈2-fold) to AP-1.5 site (Figure 6H-6J) . The binding activity of these factors to the other 3 distal potential AP-1 sites was not examined.
Discussion
Mice with null deletion of Ceacam1 (Cc1 -/-) develop systemic insulin resistance and visceral obesity resulting from impaired insulin clearance. 14, 15 The current studies demonstrate that these mice also develop albuminuria and increase in BP when fed a regular chow diet.
Elevated BP and albuminuria in Cc1 -/-mice were associated with activated renal RAS, as demonstrated by increased expression of renin, angiotensinogen, angiotensin-converting enzyme, angiotensin II, and angiotensin subtype 1 receptor in the kidney. Moreover, renal PRR level was also elevated, providing an in vivo demonstration of a role for this new member of RAS in insulin resistance associated with increased BP. Recently, several studies suggested that PRR contributes to the pathogenesis of diabetic nephropathy and conversely, reduction of its activity significantly improves renal inflammation and fibrosis in diabetes mellitus. 18, 21, [24] [25] [26] [27] [28] [29] The increase in PRR expression in Cc1 -/-kidney is mediated by activated PI3K-Akt pathway. This may seem paradoxical given the insulin resistance state in these mice. Dissociation between proximal insulin signaling and insulin resistance has been shown in humans 30 and in several models of insulin resistance, including the well-characterized Ob/Ob mouse. 31 We have detected a similar increase in basal signaling in the liver of the insulin-resistant L-SACC1 mouse with liverspecific inactivation of CEACAM1, which was attributed to activation of epidermal growth factor receptor, likely by white adipose tissue-derived plasma fatty acids and heparin-binding epidermal growth factor. 32 Thus, it is possible that a similar mechanism involving epidermal growth factor receptor activation elevates basal Akt signaling in the kidney of the insulin-resistant Cc1 -/-mice with increased visceral obesity and elevation in fatty acids release. In addition, CEACAM1 exerts a cell autonomous regulatory effect on PI3K-Akt activity, as shown by elevated basal PI3K-Akt activation in CEACAM1 knockdown IMCD cells. The underlying mechanism remains to be determined, but it is of interest that siRNA-mediated 29 Moreover, increase in PRR expression seems to be regulated by CREB family binding to CRE of PRR promoter. Inhibiting Akt kinase attenuated the function of CREB-1, ATF-1, ATF-2, and NF-κB p65 transcription factors via reduction in their phosphorylation rather than changes in their expression levels. The role of NF-κB p65 activity in PRR regulation supports our previous reports showing that transcriptional regulation of PRR by NF-κB p65 altered binding to NF-κB regulatory elements in the presence of high glucose in rat mesangial cells 15, 23 or in PT cells and IMCD cells exposed to low sodium levels. 33 In the presence of low salt, CREB-1 binding to CRE of PRR promoter increases in rat PT cells, resulting in transcriptional regulation of PRR by CREB/ATF family of transcription factors. 33 Similarly, this report showed that CEACAM1 knockdown increased binding of CREB-1, ATF-1, and ATF-2 to CRE of mouse PRR promoter in IMCD cells. Members of CREB/ATF, AP-1, and C/EBP bZIP subfamilies form homodimeric or heterodimeric complexes that bind specific DNA motifs. Several studies demonstrated that CREB/ATF influence AP-1 via protein interaction, 34 enhancing or suppressing expression of AP-1, 35 or occupying AP-1 DNA-binding elements. [36] [37] [38] Our findings demonstrated that in CEACAM1 knockdown IMCD cells, the binding of CREB-1, ATF-1, and ATF-2 to different AP-1 regulatory elements was significantly increased. These data suggest that the CREB family of transcription factors enhanced the transcriptional regulation of PRR via AP-1 DNA-binding sites in its promoter as well.
Collectively, null deletion of murine CEACAM1 activates PI3K-Akt signaling and contributes to the expression of PRR via transcription factors CREB family and NF-κB.
Perspectives
The present study demonstrates that null deletion of Ceacam1 significantly enhances renal expression of PRR via PI3K-Akt signaling pathways, CREB family, and NF-κB. These findings may help delineate new mechanisms underlying the regulation of the expression of this new RAS component in insulin resistance. Given that target deletion of Ceacam1 also causes insulin resistance, the elucidation of the mechanism underlying the effect of CEACAM1 on PRR expression promotes our understanding of the molecular link between insulin resistance, kidney disease, and hypertension, and identifies PRR as a potential therapeutic target.
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ONLINE SUPPLEMENT
MATERIALS AND METHODS
Animal Husbandry, General Biological Characteristics and Renal Interstitial Fluid Collection
Cc1
-/-null mice were generated on a mixed C57BL/6x129sv background and backcrossed 12 times onto the C57BL/6 background (S1). Animals were kept in a 12-h dark/light cycle and fed standard chow ad libitum. All protocols were approved by the Animal Care and Use Committees at the University of Virginia and the University of Toledo. Six months old male mice were studied. Before sacrifice, body weight (BW), blood glucose, plasma insulin and lipid, and systolic blood pressure (SBP) were monitored (S8). Additionally, insulin tolerance was assessed in awake mice following a 6 hour-fast starting by intra-peritoneal injection with Regular Human insulin (Novo Nordisk, 0.75U/kg BW) before drawing retro-orbital blood for glucose measurement (S8). 24 hour urine was collected as well for the evaluation of urinary level of albumin and creatinine. Renal interstitial fluid (RIF) was collected by microdialysis technique developed and successfully used in our laboratory (S2, S3) to determine angiotensin II (Ang II) level in the kidney. At the end of experiments, kidneys were harvested for protein and total RNA extraction, and parts of kidneys were also fixed with Bounin's fixative.
Cell Culture, Small Hairpin RNA Interference and Cell Treatments. Mouse renal inner medullary collecting duct epithelial cells (IMCD3) were obtained from the American Type Culture Collection (Manassas, VA) and cultured according to American Type Culture Collection recommended protocols. Cells were grown to confluence in DMEM/Nutrient Mixture F12 (Life Technologies, Grand Island, NY) supplemented with 10% fetal calf serum and antibiotics. Serum free culture or serum starvation was conducted with Opti-MEM I (Life Technologies, Grand Island, NY) for 12 hours. IMCD cells were used for small hairpin RNA transduction. Target cells were plated in a 12-well plate 24 hours prior to viral infection with complete optimal medium. When the cells reached approximately 50% confluent, a mixture of complete medium with polybrene (Santa Cruz Biotechnology, Santa Cruz, CA) at a final concentration of 5µg/ml was prepared. Media from plate wells was removed and replaced with 1 ml of this polybrene / media mixture per well. Mouse CEACAM 1 (Santa Cruz Biotechnology, Santa Cruz, CA) and control shRNA lentiviral particles (Santa Cruz Biotechnology, Santa Cruz, CA) were thawed at room temperature mixed gently before use and added to the culture to infect cells. After 24 hrs, culture medium was removed, replaced with 1 ml of complete medium and then the cells were incubated overnight. Stable clones expressing the shRNA were selected via puromycin dihydrochloride (Santa Cruz Biotechnology, Santa Cruz, CA) at final concentration of 10 µg/ml. Puromycin-containing medium was refreshed every 3-4 days until resistant colonies could be identified. Several colonies were picked and expanded. Stable shRNA expression was assessed by CEACAM 1 expression using RT-PCR, Western blot assay and immunofluorescence staining. Identified cell colonies were expanded and employed in later experiments. For the experiments with different treatments, each drug was added to serum-free medium 30 minutes before the end of serum starvation. After 30 minutes of pretreatment, cells were refreshed with serum starvation medium with or without treatment, which included following reagents: PI3K kinase inhibitor LY294002, Akt kinase inhibitor II (EMD Millipore, Billerica, MA) and CBP-CREB interaction inhibitor (CalBiochem, La Jolla, CA). Figure S3 . Lentiviral-mediated shRNA knockdown of CEACAM1 in IMCD caused a significant rise in PRR mRNA and protein expression
